Nath Bio-genes (india) Ltd. · NSE:NATHBIOGEN
Nath Bio-genes (india) — Q3 FY25 Earnings Presentation
29 slides from Nath Bio-genes (india)'s earnings presentation, Jan 25, 2025
Slide 1: Exchange cover letter for results presentation
25th January 2025 The Manager-Listing The Manager- Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code-537291 NSE Code-NATHBIOGEN Dear Sir/Madam, Subject- Presentation
Slide 2: Investor Presentation – Q3 & 9MFY25
Investor Presentation – Q3 & 9MFY25 Website www.nathbiogenes.com 1
Slide 3: Disclaimer
Disclaimer Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual
Slide 4: Competitive Positioning in a Tough Sector
Competitive Positioning in a Tough Sector Focus Area Winning Strategies Product Selection • Focus on Cotton, Wheat, Maize & Fodder Bajra • Build a dream-product basket with superior and diversified products • Empower Stakeholders; Build long-term, loyal, symbiotic relationships with our production g
Slide 5: What our Business Delivered in Last 7 Years
What our Business Delivered in Last 7 Years Average Selling Price (Rs/kg) is Increasing Revenue Growth (INR Mn) 1,311 CAGR 10% 3,326 1,917 480 209 128 FY18 FY24 FY18 FY24 Field Crops Vegetables 4
Slide 6: Tailor Made Products
2 Tailor Made Products & Understand key Develop products Focus on disease farmer requirements to suit various and pest resistance based on deep agri climatic which automatically market research. conditions results in higher yield
Slide 7: Focused on R&D
o ie Focused on R&D we, Produce Genetically Pure and Premium Quality Seeds Well Invested, DSIR recognized R&D Innovation Centers Nath Bio-Genes (India) Limited
Slide 8: Focused on Shareholder Value Creation
Focused on Shareholder Value Creation Differentiated Margin Expansion Growing Business Product Excellence Customer Growing EBITDA margins Strong Positions in Innovation and solution Experience through efficient important crops that drive productivity and operations Expanding market reach create valu
Slide 9: Farming Community’s Testimonials
Farming Community’s Testimonials 8
Slide 10: Farmers on Khushi-27
Farmers on Khushi-27 Se aMel eet egetl-27 Va cecelot fest e fiecht sun eft reeced é He tract eff afean ed wafer é | duno egett-27 a wot eige € | - dotlelails Og (PreTT)
Slide 11: Farmers on Golden-72
Farmers on Golden-72 od (rer ener mies 72 8 aR afeyy Juni feet 21 Bab clot sade otee wT th lat F ast arated aft 3a fei | € aims Ue afeaT eat el - Hera Wear, aicTrest (3ifSerr) ) GOLDEN-72 NATH PADDY SEEDS Nath Bio-Genes (India) Limited 10
Slide 12: Farmers on Super-27
Farmers on Super-27 eo NATH seeps? mel Gael GUe-27 Het Vecih ele é | Te gen et Sear aisrel fewest 2) sere ast JOH at Haeced leicht ete eet Ft rer at Oat Ge Seer Wacare Etat e | | | - Blcettcr, faci: spTer (Iaevce!) NaTH Seep SUPER-27 (NBBH-27) NATH HYBRID BAJRA SEEDS
Slide 13: Farmers on Alexander
—— #2 + < Sak Farmers on Alexander ie oneal feleten ferd-3iciesise Up sdeced fest €1 Beith thet sendy ee el sie creat Ufeaent fore aft TE 6] asl Ser feat cht afeen Tos fect e ne ALEXANDER 12
Slide 14: Farmers on NCH-2561
Farmers on NCH-2561 Ry Hot onal fate Lot ett Pa-2561 CMMs eft te del dec et EBT HOTS PETE! Se Nee Ee ON wh MrdH were sie unolne eo Ged cel ela | tearaoT 2 Gel sa feat & gen et alee sum leicht 21 = Tle 7PTAY, eile, Fic: Tetoil (ceTeTE) NCH-2561 13
Slide 15: Testimonials: Nath Sanket
| Testimonials: Nath Sanket ~ $2 3) red iN oa ‘ae! Hebd Ae Veo Haeaed HUET Vac 21 wa ead dt Ae TATer Just ect eI foe ed VT & ofa wectefict alot & wrevr carseat wT waufeedcar.. ey . NBC 1111 BG Il Cotton Hye Seeds with Bogard Technology
Slide 16: Farmers on “Super-27”
Farmers on “Super-27” ‘Bel WT Tate FUe-27 Vw Teeaed ase 2. serb fale ole vd asigd @ ste sus aft Haeaed facta &. Jom w emer are & fare aft TerHsgM WME... 19
Slide 17: Testimonials: Akhand
a Testimonials: Akhand > | Farmers on “Akhand” onal tht feds UH aedetot cace VsMctt , fied her sare Tee ect ST th eld e. hel Be Ud agg Aol h orev wes Ufeceot hee sugw e site sus ever aft Faved e. AKHAND (nt#-1912) a
Slide 18: Q3 & 9MFY25 Performance
Q3 & 9MFY25 PERFORMANCE 17
Slide 19: Key Business Highlights
Key Business Highlights • Cotton in value rose by 6.4%. • Paddy in value grew 16.6%; volume increased by 16.8%. Crop Performance • Maize in value surged by 21.3%; volume soared by 45.0%. • Bajra in value increased by 7.4%. Strategic Focus • Future strategy emphasizes continued focus on NCP segments.
Slide 20: Key Financial Highlights – 9MFY25
Key Financial Highlights – 9MFY25 Financial Performance • Incremental Revenue growth of INR 233.5 Mn YoY • Gross Margin were strong at 52.7% • EBITDA reached Rs 511.3 Mn, growing by 6.7% YoY with high margins at 16.3% • Net Profit rose by 8.1% YoY to INR 394.3 Mn ; margins stood strong at 12.6% 19
Slide 21: Key Financial Highlights – 9MFY25
Key Financial Highlights – 9MFY25 Q3FY25 YoY 9MFY25 YoY Revenue ₹ 369 Mn 16.1% ₹ 3,129 Mn 8.1% Gross Profit ₹ 244 Mn 38.5% ₹ 1,651 Mn 11.2% EBITDA ₹ 75 Mn 30.2% ₹ 511 Mn 6.7% Profits from Ordinary Business (Excluding extra ordinary items) ₹ 27 Mn 82.16% ₹ 394 Mn 8.1% 20
Slide 22: Segmental Revenue Contribution
Segmental Revenue Contribution 9MFY25 Revenue 9MFY24 Revenue INR 3,129 Mn INR 2,896 Mn Cotton Cotton, 28% 30% Others Others, 46% 45% Paddy Paddy, 26% 25% Cotton Paddy Others Cotton Paddy Others • Others include: Jowar, Bajra, Maize, Mustard, Wheat 21
Slide 23: Income Statement
Income Statement Particulars (INR Mn) 9MFY25 9MFY24 %Change (YoY) Total Revenue 3,129 2,896 8.1% Gross Profit 1,651 1,485 11.2% Gross Margin (%) 53% 51% EBITDA 511 479 6.7% EBITDA Margin (%) 16% 17% Depreciation 25 23 8.6% Finance Cost 85 80 Other Income 7 2 PBT 408 378 7.9% Tax 14 13 2.0% Tax Rate
Slide 24: Appendix
oe oy NATH seeps APPENDIX Nath Bio-Genes (India) Limited
Slide 25: Maintaining Profitability; Strong Balance Sheet
Maintaining Profitability; Strong Balance Sheet Net Debt (INR Mn) Net Worth (INR Mn) 6,133 6,107 5,576 5,734 888 5,420 5,076 4,692 679 659 672 576 478 3,033 363 328 207 1,071 1,213 -121 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 EBITDA Margin
Slide 26: Visionary Leadership; Attracting the Best Talent
Visionary Leadership; Attracting the Best Talent NATH seeps" f a pH TT. i Mil) doll AN Mr. Nandkishor Kagliwal Mr. Satish Kagliwal Chairman Managing Director Leadership Team 2 a @ Dr. Capt. Devinder Khurana Mr. Amol Gupta Dr. S.K. Raina Dr. V. N. Kulkarni Mr. K. Reddy Mr. Harish Pandey Executive Vic
Slide 27: Historical Income Statement
Historical Income Statement Nath Bio-Genes’ P&L Statement Particulars (INR Mn) FY24 FY23 FY22 FY21 FY20 Total Revenue 3,326 3,013 2,783 3,076 2,799 Gross Profit 1,991 1,667 1,544 1,715 1,536 Gross Margin (%) 60% 55% 56% 56% 55% EBITDA 504 489 373 667 547 EBITDA Margin (%) 15% 16% 13% 22% 20% Depreci
Slide 28: Historical Balance Sheet
Historical Balance Sheet Assets (INR Mn) FY24 FY23 FY22 FY21 FY20 Liabilities (INR Mn) FY24 FY23 FY22 FY21 FY20 Fixed Assets 2,406 2,340 2,329 2,333 2,308 Share Capital 190 190 190 190 190 Other Intangible 88 104 120 136 152 Assets Financial Assets 61 51 51 53 52 Reserves & Surplus 5,917 5,544 5,230
Slide 29: Thank You
Thank You CIN_NBIL_L01110MH1993PLC072842 For further information, please get in touch with: Sheetal Khanduja sheetal@GoIndiaadvisors.com M:+91 97693 64166 Monali Jain monali@GoIndiaadvisors.com M:+91 7597304020 28
Nath Bio-Genes (India) — Q3 FY25 Earnings Presentation on 6ix